The FVB/N-congenic BAC HD transgenic line L expresses multiple copies of a transgene encoding the full-length human huntingtin gene (HTT; HD or Hdh) modified to have a floxed exon 1 containing 97 mixed CAA-CAG repeats. These FVB.BAC HD (or FVB.BACHD-L) mice may be useful for studying Huntington's disease on a defined congenic background, as well as for exploring the effect of interrupted CAG tracts versus non-interrupted CAG tracts on somatic instability and RNA structure mechanisms in HD pathophysiology.
X. William Yang, University of California Los Angeles
Dr. David Howland, CHDI Foundation
Genetic Background | Generation |
---|---|
|
Allele Type |
---|
Transgenic (Conditional ready (e.g. floxed), Inserted expressed sequence, Humanized sequence) |
Stock No. 027433 was formerly associated with CHDI Foundation colony Stock No. 370192 [CHDI-81001011].
Huntington's disease (HD) is an autosomally dominant, fatal neurodegenerative disorder characterized by uncontrolled movements, psychiatric disturbances and cognitive impairment. HD is caused by an unstable trinucleotide (polyglutamine) repeat expansion in the huntingtin gene (HTT; HD or Hdh).
The BAC HD transgenic mouse line L expresses multiple copies of full-length human HTT with a mutant exon 1 containing a 97 glutamine repeat tract (mixed CAG-CAA repeats) at levels 1.5 to 2 times higher than the endogenous mouse Htt; a function of higher numbers of transgene copies inserted. Of note, the mutant exon 1 is flaked with loxP sites.
Stock No. 027433: The FVB/N-congenic BAC HD transgenic mouse line L is called FVB.BAC HD or FVB.BACHD-L. Hemizygous mice are viable, fertile and normal in size. Hemizygous mice are viable and fertile, with activity defects (hyperactivity in ~8 week old females but hyperactivity by 8 weeks [mainly in females)), abnormal gait, and motor impairment (rotarod deficit ~4 weeks of age). These mice exhibit weight gain (which can confound motor endpoint evaluation) evident in both sexes from ~4 weeks of age. Overall survival is similar to wildtype (noncarrier) mice up to 1 year of age or longer. The FVB.BACHD-L mice are not further characterized to date (April 2014).
While genetic background may lead to variations in disease severity/progression, these FVB.BACHD-L mice may exhibit a phenotype similar to that of BAC HD mice from the same founder line with less backcrossing onto the FVB/N genetic background (described and available as Stock No. 017487. Briefly, mutant HTT protein is detected in cortex, striatum, and cerebellum by Western blot analysis. qPCR results indicated that there are tandem integrations of approximately 5 copies of the transgene. The 97 CAA-CAG repeat length is stable in maternal and paternal germline transmission, as well as in brain tissue from 12 month old transgenic mice. Onset of progressive motor deficits is 2 months of age. Transgenic mice weigh 8-14% more than wildtype controls. In transgenic mice 12 months of age, a few mutant HTT protein aggregates are observed in the cortical neuropil, with tiny aggregates in the striatum, which is similar to the pattern seen in adult onset Huntington's Disease.
Importantly, if a behavioral testing battery includes cognitive tests that require the animals to use visual cues, the C57BL/6 genetic background mice may be preferred as the FVB/N genetic background imparts the Pde6brd1 mutation causing retinal degeneration and blindness at an early age. In addition, the relatively high aggression levels in FVB/N mice, especially males, may cause problems during experiments that require long-term group-housing. Conversely, mice on the C57BL/6-congenic background may exhibit age-related hearing loss and become deaf to certain frequencies.
This Huntington's disease mouse model is available by way of a collaborative effort between CHDI Foundation, Dr. X. William Yang (University of California, Los Angeles) and The Jackson Laboratory.
The BAC HD transgene was designed by Dr. X. William Yang (University of California, Los Angeles).
The 240 kbp human bacterial artificial chromosome (BAC) RP11-866L6 containing the entire 170 kbp human HTT gene, and approximately 20 kbp of 5' and 50 kbp of 3' flanking sequences, was modified by replacing exon 1 with a loxP-flanked fragment containing 97 mixed CAA-CAG repeats. The transgenic construct was microinjected into the pronucleus of FVB/N fertilized eggs. Founder line L was subsequently established and maintained on the FVB/NJ background. BAC HD mice were sent to the CHDI Foundation colony, where they were backcrossed with FVB/N inbred mice for several generations to create the FVB/N-congenic colony (FVB.BAC HD or FVB.BACHD-L), called CHDI Foundation colony Stock No. 370192 [CHDI-81001011]. In 2015, FVB.BAC HD animals from backcross generation N21-N22 were sent from the CHDI Foundation colony to The Jackson Laboratory Repository, from which FVB.BAC HD hemizygous mice are available as Stock No. 027433.
Expressed Gene | HTT, huntingtin, human |
---|---|
Site of Expression |
Allele Name | transgene insertion L, X William Yang |
---|---|
Allele Type | Transgenic (Conditional ready (e.g. floxed), Inserted expressed sequence, Humanized sequence) |
Allele Synonym(s) | BACHD-L |
Gene Symbol and Name | Tg(HTT*97Q)LXwy, transgene insertion L, X William Yang |
Gene Synonym(s) | |
Promoter | HTT, huntingtin, human |
Expressed Gene | HTT, huntingtin, human |
Strain of Origin | FVB |
Chromosome | UN |
Molecular Note | The 240 kb human bacterial artificial chromosome BAC(RP11-866L6), containing the entire 170 kb human Huntingtin (htt) genomic locus and approximately 20 kbp of 5' and 50 kbp of 3' flanking sequences, was modified by replacing the human htt exon 1 with a loxP-flanked human mutant htt exon 1 sequence (containing 97 mixed CAA-CAG repeats encoding a continuous polyglutamine (polyQ) stretch). Two lines were created (line I and L) that exhibit the same phenotype. |
Mutations Made By | X. William Yang, University of California Los Angeles |
When maintaining our live colony, hemizygous mice are bred to FVB/NJ inbred mice (Stock No. 001800).
When using the FVB.BAC HD ; BACHD on FVB/NJ back ground ; CHDI-81001011 mouse strain in a publication, please cite the originating article(s) and include JAX stock #027433 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Hemizygous or Non Carrier for Tg(HTT*97Q)LXwy |
Frozen Mouse Embryo | FVB/N-Tg(HTT*97Q)LXwy/ChdiJ Frozen Embryos | $2595.00 |
Frozen Mouse Embryo | FVB/N-Tg(HTT*97Q)LXwy/ChdiJ Frozen Embryos | $2595.00 |
Frozen Mouse Embryo | FVB/N-Tg(HTT*97Q)LXwy/ChdiJ Frozen Embryos | $3373.50 |
Frozen Mouse Embryo | FVB/N-Tg(HTT*97Q)LXwy/ChdiJ Frozen Embryos | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.